Prophylactic Effect of Intravenous Lidocaine Against Cognitive Deficit After Cardiac Surgery: A PRISMA-compliant Meta-analysis and Trial Sequential Analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2022 Sep 15

PMID 36107567

Authors

Kuo-Chuan Hung

Chun-Ning Ho

Wei-Cheng Liu

Ming Yew

Ying-Jen Chang

Yao-Tsung Lin

I-Yin Hung

Jen-Yin Chen

Ping-Wen Huang

Cheuk-Kwan Sun

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed at providing an updated evidence of the association between intraoperative lidocaine and risk of postcardiac surgery cognitive deficit.

Methods: Randomized clinical trials (RCTs) investigating effects of intravenous lidocaine against cognitive deficit in adults undergoing cardiac surgeries were retrieved from the EMBASE, MEDLINE, Google scholar, and Cochrane controlled trials register databases from inception till May 2021. Risk of cognitive deficit was the primary endpoint, while secondary endpoints were length of stay (LOS) in intensive care unit/hospital. Impact of individual studies and cumulative evidence reliability were evaluated with sensitivity analyses and trial sequential analysis, respectively.

Results: Six RCTs involving 963 patients published from 1999 to 2019 were included. In early postoperative period (i.e., 2 weeks), the use of intravenous lidocaine (overall incidence = 14.8%) was associated with a lower risk of cognitive deficit compared to that with placebo (overall incidence = 33.1%) (relative risk = 0.49, 95% confidence interval: 0.32-0.75). However, sensitivity analysis and trial sequential analysis signified insufficient evidence to arrive at a firm conclusion. In the late postoperative period (i.e., 6-10 weeks), perioperative intravenous lidocaine (overall incidence = 37.9%) did not reduce the risk of cognitive deficit (relative risk = 0.99, 95% confidence interval: 0.84) compared to the placebo (overall incidence = 38.6%). Intravenous lidocaine was associated with a shortened LOS in intensive care unit/hospital with weak evidence.

Conclusion: Our results indicated a prophylactic effect of intravenous lidocaine against cognitive deficit only at the early postoperative period despite insufficient evidence. Further large-scale studies are warranted to assess its use for the prevention of cognitive deficit and enhancement of recovery (e.g., LOS).

Citing Articles

Cerebral Protection Strategies in Aortic Arch Surgery-Past Developments, Current Evidence, and Future Innovation.

Werner P, Winter M, Mahr S, Stelzmueller M, Zimpfer D, Ehrlich M Bioengineering (Basel). 2024; 11(8).

PMID: 39199732 PMC: 11351742. DOI: 10.3390/bioengineering11080775.

References

Baradari A, Habibi M, Habibi V, Nouraei S . Administration of lidocaine to prevent cognitive deficit in patients undergoing coronary artery bypass grafting and valve plasty: a systematic review and meta-analysis. Expert Rev Clin Pharmacol. 2016; 10(2):179-185. DOI: 10.1080/17512433.2017.1266252. View

Dutka A, Mink R, McDermott J, Clark J, Hallenbeck J . Effect of lidocaine on somatosensory evoked response and cerebral blood flow after canine cerebral air embolism. Stroke. 1992; 23(10):1515-20; discussion 1520-1. DOI: 10.1161/01.str.23.10.1515. View

Canyon S, Dobson G . Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat. Am J Physiol Heart Circ Physiol. 2004; 287(3):H1286-95. DOI: 10.1152/ajpheart.00273.2004. View

Grigore A, Mathew J, Grocott H, Reves J, Blumenthal J, White W . Prospective randomized trial of normothermic versus hypothermic cardiopulmonary bypass on cognitive function after coronary artery bypass graft surgery. Anesthesiology. 2001; 95(5):1110-9. DOI: 10.1097/00000542-200111000-00014. View

Kaczmarek D, Herzog C, Larmann J, Gillmann H, Hildebrand R, Schmitz M . Lidocaine protects from myocardial damage due to ischemia and reperfusion in mice by its antiapoptotic effects. Anesthesiology. 2009; 110(5):1041-9. DOI: 10.1097/ALN.0b013e31819dabda. View

Weber M, Taylor C . Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and phenytoin without blockade of action potentials. Brain Res. 1994; 664(1-2):167-77. DOI: 10.1016/0006-8993(94)91967-4. View

Dobson G, Jones M . Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg. 2004; 127(3):794-805. DOI: 10.1016/s0022-5223(03)01192-9. View

Ghaffary S, Ghaeli P, Talasaz A, Karimi A, Noroozian M, Salehiomran A . Effect of memantine on post-operative cognitive dysfunction after cardiac surgeries: a randomized clinical trial. Daru. 2017; 25(1):24. PMC: 5696736. DOI: 10.1186/s40199-017-0190-0. View

Brok J, Thorlund K, Wetterslev J, Gluud C . Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2008; 38(1):287-98. DOI: 10.1093/ije/dyn188. View

10.

Klinger R, Cooter M, Bisanar T, Terrando N, Berger M, Podgoreanu M . Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial. Anesthesiology. 2019; 130(6):958-970. PMC: 6520120. DOI: 10.1097/ALN.0000000000002668. View

11.

Liu Y, Zhang J, Zan J, Zhang F, Liu G, Wu A . Lidocaine improves cerebral ischemia-reperfusion injury in rats through cAMP/PKA signaling pathway. Exp Ther Med. 2020; 20(1):495-499. PMC: 7271727. DOI: 10.3892/etm.2020.8688. View

12.

Tao R, Wang X, Pang L, Cheng J, Wang Y, Gao G . Pharmacologic prevention of postoperative delirium after on-pump cardiac surgery: A meta-analysis of randomized trials. Medicine (Baltimore). 2018; 97(43):e12771. PMC: 6221693. DOI: 10.1097/MD.0000000000012771. View

13.

Chung C, Pimentel D, Jordan A, Hao Y, Milberg W, Novak V . Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes. Neurology. 2015; 85(5):450-8. PMC: 4534073. DOI: 10.1212/WNL.0000000000001820. View

14.

Jiao X, Lin X, Ni X, Li H, Zhang C, Yang C . Volatile anesthetics versus total intravenous anesthesia in patients undergoing coronary artery bypass grafting: An updated meta-analysis and trial sequential analysis of randomized controlled trials. PLoS One. 2019; 14(10):e0224562. PMC: 6818786. DOI: 10.1371/journal.pone.0224562. View

15.

Selnes O, Goldsborough M, Borowicz L, McKhann G . Neurobehavioural sequelae of cardiopulmonary bypass. Lancet. 1999; 353(9164):1601-6. DOI: 10.1016/S0140-6736(98)07576-X. View

16.

Arrowsmith J, Harrison M, Newman S, Stygall J, Timberlake N, Pugsley W . Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke. 1998; 29(11):2357-62. DOI: 10.1161/01.str.29.11.2357. View

17.

Ghafari R, Baradari A, Firouzian A, Nouraei M, Aarabi M, Zamani A . Cognitive deficit in first-time coronary artery bypass graft patients: a randomized clinical trial of lidocaine versus procaine hydrochloride. Perfusion. 2012; 27(4):320-5. DOI: 10.1177/0267659112446525. View

18.

Nemeth E, Vig K, Racz K, Koritsanszky K, Ronkay K, Hamvas F . Influence of the postoperative inflammatory response on cognitive decline in elderly patients undergoing on-pump cardiac surgery: a controlled, prospective observational study. BMC Anesthesiol. 2017; 17(1):113. PMC: 5576316. DOI: 10.1186/s12871-017-0408-1. View

19.

Butwell N, Ramasamy R, Lazar I, Sherry A, Malloy C . Effect of lidocaine on contracture, intracellular sodium, and pH in ischemic rat hearts. Am J Physiol. 1993; 264(6 Pt 2):H1884-9. DOI: 10.1152/ajpheart.1993.264.6.H1884. View

20.

Astrup J, Sorensen P, SORENSEN H . Inhibition of cerebral oxygen and glucose consumption in the dog by hypothermia, pentobarbital, and lidocaine. Anesthesiology. 1981; 55(3):263-8. DOI: 10.1097/00000542-198109000-00013. View